Quest Diagnostics Incorporated logo
DGXQuest Diagnostics Incorporated

Earnings Per Share (EPS): 9.05

popular:market cap|pe ratio|revenue|price history|total return

Is the earnings per share (EPS) high or low?

The earnings per share (EPS) of 9.05 is in line with its 5-year average of 9.83, near the low end of its 5-year range (7.59–15.90).

As of Friday, June 26, 2026. 8.58% above its 12-month average of 8.33.

P/E Ratio|EPS CAGR|Net Income|Earnings Yield|All Metrics
EPS

DGX Earnings Per Share (EPS)

2.27

Reported quarterly EPS; no daily interpolation.

-55.05% 5Y

DGX Quarterly EPS Growth (YoY)

EPS growth vs the same quarter one year earlier, last 20 quarters.

DGX Earnings Per Share (EPS)

DGX Average Earnings Per Share (EPS) Chart

DGX Earnings Per Share (EPS)

DGX Current vs Average Earnings Per Share (EPS) Chart

DGX Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

9.05

EARNINGS PER SHARE (EPS) AVG TTM

8.33

EARNINGS PER SHARE (EPS) AVG 3Y

8.09

EARNINGS PER SHARE (EPS) AVG 5Y

9.83

EARNINGS PER SHARE (EPS) AVG 10Y

7.81

EARNINGS PER SHARE (EPS) AVG 15Y

5.99

EARNINGS PER SHARE (EPS) AVG 20Y

5.21

CURRENT VS TTM AVG

+8.58%

CURRENT VS 3Y AVG

+11.80%

CURRENT VS 5Y AVG

-7.90%

CURRENT VS 10Y AVG

+15.92%

CURRENT VS 15Y AVG

+50.98%

CURRENT VS 20Y AVG

+73.60%

DGX Competitors' Earnings Per Share (EPS)

NAMEMARKET CAPEARNINGS PER SHARE (EPS)TTM3Y5Y
Quest Diagnostics Incorporated (DGX)$22.83B9.058.338.099.83
BioNTech SE (BNTX)vs ›$22.76B-5.94-4.089.2114.48
United Therapeutics Corporation (UTHR)vs ›$23.07B27.0528.2923.4019.31
Moderna, Inc. (MRNA)vs ›$23.71B-8.15-8.27-1.903.46
Labcorp Holdings Inc. (LH)vs ›$21.83B11.299.719.5713.14
Incyte Corporation (INCY)vs ›$21.48B7.083.382.742.31
Waters Corporation (WAT)vs ›$24.57B7.8710.7811.0510.65
Mettler-Toledo International Inc. (MTD)vs ›$25.13B42.7141.4239.4336.04
STERIS plc (STE)vs ›$20.52B7.937.084.774.37
Veeva Systems Inc. (VEEV)vs ›$25.68B5.614.984.093.61

EPS Comparison

Trailing EPS (TTM)

$9.05

Forward EPS (Est.)

$11.67

P/E Ratio

22.8

Formula: EPS = Net Income / Weighted Average Shares Outstanding

Why EPS matters:

  • Directly impacts stock valuation through P/E ratio
  • Used to calculate dividend coverage and payout ratios
  • Enables comparison across companies of different sizes
  • Growth in EPS often correlates with stock price appreciation

Earnings Per Share (EPS) Formula & Definition

EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for Quest Diagnostics Incorporated (DGX)?
The earnings per share (EPS) for DGX stock is 9.05.
Is Quest Diagnostics Incorporated's earnings per share (EPS) high or low?
The earnings per share (EPS) of 9.05 is in line with its 5-year average of 9.83, near the low end of its 5-year range (7.59–15.90).
What is the TTM average earnings per share (EPS) for Quest Diagnostics Incorporated (DGX)?
The TTM average earnings per share (EPS) for DGX stock is 8.33.
What is the 3Y average earnings per share (EPS) for Quest Diagnostics Incorporated (DGX)?
The 3Y average earnings per share (EPS) for DGX stock is 8.09.
What is the 5Y average earnings per share (EPS) for Quest Diagnostics Incorporated (DGX)?
The 5Y average earnings per share (EPS) for DGX stock is 9.83.
What is the 10Y average earnings per share (EPS) for Quest Diagnostics Incorporated (DGX)?
The 10Y average earnings per share (EPS) for DGX stock is 7.81.
What is the 15Y average earnings per share (EPS) for Quest Diagnostics Incorporated (DGX)?
The 15Y average earnings per share (EPS) for DGX stock is 5.99.
What is the 20Y average earnings per share (EPS) for Quest Diagnostics Incorporated (DGX)?
The 20Y average earnings per share (EPS) for DGX stock is 5.21.

DGX Earnings Per Share (EPS) History

DATEEARNINGS PER SHARE (EPS)
2025-12-318.87
2024-12-317.80
2023-12-317.59
2022-12-318.12
2021-12-3115.90
2020-12-3110.68
2019-12-316.38
2018-12-315.41
2017-12-315.63
2016-12-314.58
2015-12-314.92
2014-12-313.83
2013-12-315.58
2012-12-313.49
2011-12-312.95
2010-12-314.08
2009-12-313.91
2008-12-312.99
2007-12-311.76
2006-12-312.98
2005-12-312.71
2004-12-312.45
2003-12-312.11
2002-12-311.67
2001-12-310.87
2000-12-310.57
1999-12-31-0.03
1998-12-310.23
1997-12-31-0.19
1996-12-31-5.33

Related Metrics

P/E RatioEPS CAGRNet IncomeEarnings YieldAll Metrics

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Secaucus, NJ
55,000 employees
www.questdiagnostics.com
Healthcare / Medical - Diagnostics & Research
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James E. Davis
View full financials